序号	中文	英文	操作
201	Jean Marie Vianney Habarugira, on behalf of the European & Developing Countries Clinical Trials Partnership (EDCTP)	Jean Marie Vianney Habarugira, on behalf of the European & Developing Countries Clinical Trials Partnership (EDCTP)	查看中文全文00003 查看英文全文00003
202	Veronika von Messling, on behalf of German Federal Ministry of Education and Research, Germany	Veronika von Messling, on behalf of German Federal Ministry of Education and Research, Germany	查看中文全文00003 查看英文全文00003
203	Tony T. Wang, Food and Drug Administration, U.S. Department of Health and Human Services, USA	Tony T. Wang, Food and Drug Administration, U.S. Department of Health and Human Services, USA	查看中文全文00003 查看英文全文00003
204	Jeffrey Wolf, Heat Biologics Inc, USA	Jeffrey Wolf, Heat Biologics Inc, USA	查看中文全文00003 查看英文全文00003
205	Ningshao Xia, Xiamen University of China, China	Ningshao Xia, Xiamen University of China, China	查看中文全文00003 查看英文全文00003
206	Yingjie Xu, on behalf of Shanghai Jiaotong University, China	Yingjie Xu, on behalf of Shanghai Jiaotong University, China	查看中文全文00003 查看英文全文00003
207	Paul R Young, University of Queensland, Australia	Paul R Young, University of Queensland, Australia	查看中文全文00003 查看英文全文00003
208	Hang Yu, on behalf of Shanghai RNACure, China	Hang Yu, on behalf of Shanghai RNACure, China	查看中文全文00003 查看英文全文00003
209	Xuefeng Yu, CanSino Biologics, China	Xuefeng Yu, CanSino Biologics, China	查看中文全文00003 查看英文全文00003
210	Tal Zaks, on behalf of Moderna, USA	Tal Zaks, on behalf of Moderna, USA	查看中文全文00003 查看英文全文00003